Option Extension Fee Clause Samples

Option Extension Fee. If SB elects to extend the [***] Option Period pursuant to Section 2(c) above, on or before the expiration of the initial [***] Option Period, SB shall pay to Corixa a lump sum payment of [***] by wire transfer of immediately available funds, which payment shall be subject to credit, conversion or repayment as set forth in Section 4 below.
Option Extension Fee. If SB elects to extend the Colon Option Period pursuant to Section 2(c) above, on or before the expiration of the initial Colon Option Period, SB shall pay to Corixa a lump sum payment of Two Million United States Dollars (US$2,000,000) by wire transfer of immediately available funds, which payment shall be subject to credit, conversion or repayment as set forth in Section 4 below.
Option Extension Fee. As set forth in in Article 1.6 of the Agreement: “Option Period” shall mean the period ending nine (9) months after the Effective Date. The Option Period may be extendable by an additional nine (9) months, subject to the payment of the Option Extension Fee of two thousand U.S. dollars ($2,000.00). Optionee must provide notice to Licensor of its intent to pay the Option Extension Fee one (1) month prior to the expiration of the initial Option Period, and must pay the Option Extension Fee no later than the last day of the initial Option Period. The Option Extension Fee is nonrefundable, non-creditable and is not an advance against any other payment or obligation, including the License Fee and Earned Royalties. Unless as otherwise agreed to by the parties in writing and executed by each Party’s authorized representative, only one extension of the Option Period is allowed.
Option Extension Fee. Upon extension of the Option Period pursuant to Section 4.3, Amgen shall pay Arrowhead an additional [***] Dollars ($[***]) for each such extension. In no event shall Amgen be obligated to pay more than [***] Dollars ($[***]) per extension or more than [***] Dollars ($[***]) in the aggregate for the four extensions permitted under Section 4.3.
Option Extension Fee. In consideration for the parties entering into that certain Amendment to Collaboration, Option and License Agreement, by and between the parties, dated January 25, 2018 (the “Amendment”), Editas shall make a one-time, non-refundable, noncreditable payment to Adverum of five hundred thousand dollars ($500,000.00) within [*] days after the effective date of the Amendment, provided, that Adverum has provided an invoice for such payment to ▇▇▇▇▇▇▇▇.▇▇▇▇▇▇▇@▇▇▇▇▇▇▇▇▇.▇▇▇.
Option Extension Fee. In consideration of the extension of the option for an additional twelve (12) month period, COMPANY shall pay to MSU a non-refundable option extension fee in the amount of _________ dollars ($________) which shall be due and payable upon notice to extend said option period.
Option Extension Fee. Within thirty (30) days after notification of ICT by GlycArt that it wants the extension pursuant to Section 2.1(c) and receipt of an invoice from ICT, GlycArt shall pay to ICT [***].
Option Extension Fee. If the FDA Decision Date does not occur before December 15, 2023 and AbbVie has not delivered an Option Exercise Notice to Licensor, then AbbVie shall have the right, until 11:59:59 p.m. Central Time on December 22, 2023, to pay Licensor a non-refundable payment equal to Five Million Dollars ($5,000,000) (the “Option Extension Fee”) in consideration for extending the Exercise Period to the earlier of (a) the tenth (10th) Business Day after the FDA Decision Date and (b) the date that is eighteen (18) months after the Effective Date. If the Parties execute the License Agreement, then any Option Extension Fee paid to Licensor shall be credited against the upfront payment under Section 6.1 of the License Agreement.
Option Extension Fee. If SB elects to extend the Ovarian Option Period pursuant to Section 3(c) above, on or before the expiration of the initial Ovarian Option Period, SB shall pay to Corixa a lump sum payment of Two Million United States Dollars (US$2,000,000) by wire transfer of immediately available funds, which payment shall be subject to credit, conversion or repayment as set forth in Section 4 below.